Recursion Pharmaceuticals (RXRX) EPS (Basic) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted EPS (Basic) of -$0.22 for Q1 2026, up 8.13% on a QoQ basis from -$0.24 in Q4 2025, and up 55.84% year-over-year from -$0.14 in Q1 2025.
Recursion Pharmaceuticals (RXRX) EPS (Basic) (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.22 for Q1 2026.
- Quarterly EPS (Basic) rose 55.84% year-over-year to -$0.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.06 (up 25.89% YoY) and the FY2025 annual result came in at -$1.44, up 14.78% from the prior year.
- EPS (Basic) was -$0.22 for Q1 2026 at Recursion Pharmaceuticals, up from -$0.24 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.22 in Q1 2026 and bottomed at -$0.65 in Q4 2024.
- A 5-year average of -$0.39 and a median of -$0.38 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 75.42% — and 2024, when it tumbled 45.83%.
- Recursion Pharmaceuticals' EPS (Basic) stood at -$0.37 in 2022, then declined by 21.69% to -$0.45 in 2023, then slumped by 45.83% to -$0.65 in 2024, then surged by 62.96% to -$0.24 in 2025, then grew by 8.13% to -$0.22 in 2026.
- Business Quant data shows RXRX's EPS (Basic) at -$0.22 in Q1 2026, -$0.24 in Q4 2025, and -$0.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Recursion Pharmaceuticals | 1.57 Bn | 912.05 Mn | -6.02 Mn | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.41 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -0.65 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.39 |
| Dec 31, 2023 | -0.45 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | -0.37 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | -0.28 |
| Jun 30, 2021 | -0.31 |